Can Labeling Reduce the Risk of Misconnections?

Patients receiving multiple, concurrent intravenous (IV) infusions often face a serious risk—the potential for misconnected tubing lines and dosing error. “Nurses check lines to make sure there are no mix-ups, unintended disconnections, or wrong doses. The consequences can be severe,” explained Elmer Vera, a registered nurse working in critical care for 18 years. “As the treatments for ailments become more advanced, the danger associated with multiple IV infusions continue to take lives right before the very eyes of the people who are responsible for their care, the nurses. Critically ill patients are particularly vulnerable because they receive multiple interventions with potent agents via numerous IV access routes. Errors are more frequent and fatal in neonatal and pediatric ICUs. Practices  are particularly  prone to errors, a glaring gap in the current standards.” And no matter how careful nurses are, the risks still exist. “Your fingers can play tricks on you when you trace the line,” he added. Vera told MD+DI that he noticed the challenges involved in ensuring proper connections when he began working as a nurse. So he decided he’d devise a better solution for “tracing the line.” The risks had also hit home for Vera. His son had been diagnosed with Stage 4 No...
Source: MDDI - Category: Medical Devices Authors: Tags: Labeling Source Type: news

Related Links:

Publication date: March 2020Source: Human Pathology: Case Reports, Volume 19Author(s): Atif Saleem, Rohan Joshi, Li Lei, Lhara Lezama, Shyam S. Raghavan, Nastaran Neishaboori, Mohana Roy, Joe Schroers-Martin, Gregory W. Charville, Christian Kunder, Brent Tan, Beth A. Martin, Yasodha Natkunam
Source: Human Pathology: Case Reports - Category: Pathology Source Type: research
Publication date: March 2020Source: The Lancet Haematology, Volume 7, Issue 3Author(s): Motoharu Shibusawa
Source: The Lancet Haematology - Category: Hematology Source Type: research
Publication date: Available online 26 February 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Ben Ponvilawan, Nipith Charoenngam, Thanitsara Rittiphairoj, Patompong Ungprasert
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Authors: Micieli A, Ghorab Z, Micieli JA PMID: 32094269 [PubMed - in process]
Source: Canadian Medical Association Journal - Category: General Medicine Tags: CMAJ Source Type: research
Conference abstracts
Source: The Aspergillus Website - updates - Category: Respiratory Medicine Authors: Source Type: news
Conditions:   High Grade B-Cell Lymphoma, Not Otherwise Specified;   Recurrent Burkitt Lymphoma;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements;   Refractory Burkitt Lymphoma;   Refractory Diffuse Large B-Cell Lymphom a;   Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements Interventions:   Drug: Bortezomib;   Biological: Rituximab;   Drug: Venetoclax Sponsors:   Rutgers, The State&nb...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Ectomesenchymoma;   Recurrent Adrenal Gland Pheochromocytoma;   Recurrent Ependymoma;   Recurrent Ewing Sarcoma;   Recurrent Hepatoblastoma;   Recurrent Langerhans Cell Histiocytosis;   Recurrent Malignant Germ Cell Tumor;   Recurrent Malignant Glioma;   Recurrent Medull oblastoma;   Recurrent Melanoma;   Recurrent Neuroblastoma;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Osteosarcoma;   Recurrent Peripheral Primitive Neuroectode...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionThese results indicate that DLBCL tends to occur late in pSS cases and is mainly related to the non ‐GCB subtype of DLBCL.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Tags: ORIGINAL ARTICLE Source Type: research
CONCLUSIONS: XIST protects cardiomyocytes from hypoxia-induced injury by mediating miR-150-5p/Bax axis, suggesting that XIST is an important target for AMI treatment. PMID: 32096185 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
In this study, the model of MI was established in rats through ligating the left anterior descending coronary artery. Subsequently, the messenger ribonucleic acid (mRNA) and protein expression levels of TGF-β1 in myocardial cells in both model group and sham operation group were determined. The effects of TGF-β1 treatment on myocardial cell apoptosis in MI rats were explored. Moreover, the changes of mitogen-activated protein kinase (MAPK) signaling pathway in rats with acute MI were verified. In addition, the protein expressions of phosphorylated-MAPK kinases 3/6 (p-MKK3/6) and MKK3/6 in myocardial cells of the ...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Canada Health | Cancer & Oncology | Eyes | Hospitals | Laboratory Medicine | Lymphoma | Medical Devices | Nurses | Nursing | Pediatrics | Perinatology & Neonatology | Study